Impact of Home-based Cardiac Rehabilitation on Outcomes After TAVR (HBCR-TAVR)
A Study of the Impact of Home-based Cardiac Rehabilitation on Outcomes After Transcatheter Aortic Valve Replacement (TAVR)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Xiaoya Wang, Doctor
- Phone Number: +86-15715702712
- Email: wxyonce@zju.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310000
- Recruiting
- The Second Affiliated Hospital of Zhejiang University, School of Medicine
-
Contact:
- Xiaoya Wang, Doctor
- Phone Number: 15715702712
- Email: wxyonce@zju.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aortic stenosis accepted for TAVR
- Participant able and willing to give written informed consent
- Participant able (in the investigator's opinion) and willing to comply with all study requirements
Exclusion Criteria: subjects may not enter the study if any of the following apply
- Intervention deemed inappropriate due to co-morbidity or frailty
- Life expectancy less than one year due to co-morbidity
- Previous surgical aortic valve replacement (sAVR) or TAVR
- Predominant aortic regurgitation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Control Group
Routine care
|
Routine care and followup
|
|
Experimental: Interventional Group
Home-based cardiac rehabilitation
|
cardiac rehabilitation done at home
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-minute walk test
Time Frame: 6 weeks
|
The total distance walked in meters during 6 minutes.
|
6 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants die
Time Frame: 6 weeks, 12 months
|
Number of participants die during the study due to cardiovascular or non-cardiovascular causes.
|
6 weeks, 12 months
|
|
Number of participants rehospitalized
Time Frame: 6 weeks, 12 months
|
Number of participants rehospitalized during the study.
|
6 weeks, 12 months
|
|
Number of participants completing home-based cardiac rehabilitation
Time Frame: 6 weeks
|
Number of participants completing home-based cardiac rehabilitation
|
6 weeks
|
|
Cardiac function
Time Frame: 12 months
|
Ejection fraction estimated by echocardiography
|
12 months
|
|
Aortic valve function
Time Frame: 12 months
|
Aortic valve function estimated by echocardiography
|
12 months
|
|
Number of participants injured
Time Frame: 6 weeks
|
Number of participants injured or die during the course of home-based cardiac rehabilitation
|
6 weeks
|
|
Time spent performing activities
Time Frame: 6 weeks, 12 months
|
Number of minutes in a typical week that participants spent performing activities
|
6 weeks, 12 months
|
|
6-minute walk test
Time Frame: 12 months
|
The total distance walked in meters during 6 minutes
|
12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Xianbao Liu, Doctor, Second Affiliated Hospital, School of Medicine, Zhejiang University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ZJUWXY
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.